These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cisplatin in isolated limb perfusion. Roseman JM Am J Surg; 1989 Mar; 157(3):366. PubMed ID: 2919745 [No Abstract] [Full Text] [Related]
24. The role of hyperthermic perfusion in the treatment of tumors of the extremities. Di Filippo F; Carlini S; Cavaliere F; Giannarelli D; Cavallero L; Moscarelli F; Aloe L; Cavaliere R Adv Exp Med Biol; 1990; 267():223-34. PubMed ID: 2088040 [No Abstract] [Full Text] [Related]
25. Phase I-II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremities. Hajarizadeh H; Mueller CR; Woltering EA; Small K; Fletcher WS Melanoma Res; 1991; 1(1):55-61. PubMed ID: 1822770 [TBL] [Abstract][Full Text] [Related]
26. [Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas]. Alegre JF; Duarte M; Sureda González M; Bretcha Boix P; Dussan C; Ballester A; Crespo A; Brugarolas Masllorens A Cir Esp; 2012 Feb; 90(2):114-20. PubMed ID: 22225611 [TBL] [Abstract][Full Text] [Related]
27. Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma. Möller MG; Lewis JM; Dessureault S; Zager JS Int J Hyperthermia; 2008 May; 24(3):275-89. PubMed ID: 18393005 [TBL] [Abstract][Full Text] [Related]
28. Improved survival for soft tissue sarcoma of the extremities by regional hyperthermic perfusion, local excision and radiation therapy. Lehti PM; Moseley HS; Janoff K; Stevens K; Fletcher WS Surg Gynecol Obstet; 1986 Feb; 162(2):149-52. PubMed ID: 3945892 [TBL] [Abstract][Full Text] [Related]
30. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient. Bonvalot S; Rimareix F; Causeret S; Le Péchoux C; Boulet B; Terrier P; Le Cesne A; Muret J Ann Surg Oncol; 2009 Dec; 16(12):3350-7. PubMed ID: 19830495 [TBL] [Abstract][Full Text] [Related]
31. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926 [TBL] [Abstract][Full Text] [Related]
32. Hyperthermic isolated regional perfusion with CDDP for bone and soft-tissue sarcoma of the lower limb: pharmacokinetics, thermal dose, toxicity, and feasibility. Abe S; Tokizaki T; Miki Y; Tateishi A; Ogawa K; Nakano H; Matsushita T Cancer Chemother Pharmacol; 2005 Jul; 56(1):55-62. PubMed ID: 15791455 [TBL] [Abstract][Full Text] [Related]
33. Regional perfusion for malignant melanoma and soft tissue sarcoma: a review. Muchmore JH; Carter RD; Krementz ET Cancer Invest; 1985; 3(2):129-43. PubMed ID: 3888352 [No Abstract] [Full Text] [Related]
34. Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity. Eroglu A; Kocaoglu H; Demirci S; Akgül H Eur J Surg Oncol; 2000 Apr; 26(3):213-21. PubMed ID: 10753532 [TBL] [Abstract][Full Text] [Related]
36. Hyperthermic isolated regional perfusion of the limb with carboplatin. Daryanani D; de Vries EG; Guchelaar HJ; van Weerden TW; Hoekstra HJ Eur J Surg Oncol; 2000 Dec; 26(8):792-7. PubMed ID: 11087648 [TBL] [Abstract][Full Text] [Related]
37. Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Komdeur R; Plaat BE; Hoekstra HJ; Molenaar WM; Hollema H; van den Berg E; Mastik MF; van der Graaf WT Cancer; 2001 May; 91(10):1940-8. PubMed ID: 11346877 [TBL] [Abstract][Full Text] [Related]
38. Hyperthermic isolated limb perfusion with cisplatin in four patients with sarcomas of soft tissue and bone. van Ginkel RJ; Schraffordt Koops H; de Vries EG; Molenaar WM; Uges DR; Hoekstra HJ Eur J Surg Oncol; 1996 Oct; 22(5):528-31. PubMed ID: 8903498 [TBL] [Abstract][Full Text] [Related]
39. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Eggermont AM; Schraffordt Koops H; Klausner JM; Kroon BB; Schlag PM; Liénard D; van Geel AN; Hoekstra HJ; Meller I; Nieweg OE; Kettelhack C; Ben-Ari G; Pector JC; Lejeune FJ Ann Surg; 1996 Dec; 224(6):756-64; discussion 764-5. PubMed ID: 8968230 [TBL] [Abstract][Full Text] [Related]
40. 15 years' experience with hyperthermic perfusion for treatment of soft tissue sarcoma and malignant melanoma of the extremities. Stehlin JS; Giovanella BC; Gutierrez AE; de Ipolyi PD; Greeff PJ Front Radiat Ther Oncol; 1984; 18():177-82. PubMed ID: 6706133 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]